The treatment of pancreatic cancer, a neoplasm that affects more than 4,000 people in Spain alone, and significantly reduces the life expectancy of those affected, is much more effective if it is accompanied by adequate nutrition to the special needs of these patients.
In the framework of the XIII Meeting of the Pancreatic Spanish Club, which has recently gathered in Barcelona, 185 experts in diseases of the pancreas, Dr. Enrique Domínguez-Muñoz, head of the digestive service of the Clinical Hospital of Santiago de Compostela, said that in A retrospective study with patients with advanced pancreatic cancer, pancreatic enzyme treatment and nutritional support was associated with a mean survival of 301 days compared to 89 days in the case of patients who did not receive such therapy.
If the pancreas does not function properly, the absorption of nutrients is impeded and the patient suffers malnutrition, which decreases their quality of life and worsens the prognosis of cancer.
When the pancreas does not perform its function correctly, as it can happen when it is affected by a cancer, it can cause a exocrine pancreatic insufficiency that prevents absorption of nutrients and, as a result of this, the patient suffers from malnutrition, which significantly reduces their quality of life and worsens the prognosis of the disease, as explained by the organizer of the event, Dr. Jaume Boadas, head of the Digestive Service of the Hospital de Terrassa
During the meeting, the specialists also addressed other pathologies of the pancreas such as acute pancreatitis or autoimmune pancreatitis, and shared their knowledge about these and other diseases, as well as about the latest advances that have occurred in their treatment. Thus, for example, Dr. Jonas Rosendhal, a researcher at the University of Leipzig wanted to highlight the important influence it has on chronic pancreatitis, not only tobacco and alcohol-usual risk factors-but also genetics.
Source: Spanish Pancreatic Club